Citigroup’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $809M | Buy |
|
|||||
|
2021
Q1 | $502M | Buy |
|
|||||
|
2020
Q4 | $175M | Buy |
|
|||||
|
2020
Q3 | $96.5M | Buy |
|
|||||
|
2020
Q2 | $89.2M | Buy |
|
|||||
|
2020
Q1 | $65.1M | Sell |
|
|||||
|
2019
Q4 | $81M | Sell |
|
|||||
|
2019
Q3 | $79.4M | Buy |
|
|||||
|
2019
Q2 | $87.3M | Buy |
|
|||||
|
2019
Q1 | $59.2M | Buy |
|
|||||
|
2018
Q4 | $26.3M | Buy |
|
|||||
|
2018
Q3 | $29.1M | Buy |
|
|||||
|
2018
Q2 | $22.2M | Sell |
|
|||||
|
2018
Q1 | $24.2M | Buy |
|
|||||
|
2017
Q4 | $17.8M | Buy |
|
|||||
|
2017
Q3 | $17.4M | Sell |
|
|||||
|
2017
Q2 | $17.3M | Buy |
|
|||||
|
2017
Q1 | $10.3M | Sell |
|
|||||
|
2016
Q4 | $20.6M | Buy |
|
|||||
|
2016
Q3 | $6.97M | Buy |
|
|||||
|
2016
Q2 | $5.8M | Sell |
|
|||||
|
2016
Q1 | $7.47M | Buy |
|
|||||
|
2015
Q4 | $8.84M | Sell |
|
|||||
|
2015
Q3 | $18M | Sell |
|
|||||
|
2015
Q2 | $23.1M | Buy |
|
|||||
|
2015
Q1 | $17.3M | Buy |
|
|||||
|
2014
Q4 | $15.8M | Buy |
|
|||||
|
2014
Q3 | $10.3M | Sell |
|
|||||
|
2014
Q2 | $12.8M | Buy |
|
|||||
|
2014
Q1 | $12.2M | Sell |
|
|||||
|
2013
Q4 | $26.5M | Buy |
|
|||||
|
2013
Q3 | $23.1M | Sell |
|
|||||
|
2013
Q2 | $18.5M | Buy |
|